PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
05-Jan-2022 Barrow Neurological Institute Selects Cubresa’s BrainPET System to Support Neurological Research Activities Businesswire
05-Jan-2022 Leronlimab 14-Week, NASH Clinical Trial Met Primary Endpoint (PDFF) and Secondary Endpoint (cT1) for Per Protocol Population in 350 mg Weekly Dose Businesswire
05-Jan-2022 MyMD Pharmaceuticals Announces Issuance of New U.S. Patent Covering MYMD-1 in a Method of Treating Sarcopenia Businesswire
05-Jan-2022 Global Wearable Injectors Market Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2015-2026 - ResearchAndMarkets.com Businesswire
05-Jan-2022 Fish & Richardson Elevates 17 Attorneys to Principal Businesswire
05-Jan-2022 Suono Bio, Inc. Announces Formulation-Agnostic Platform for the Delivery of RNA Therapeutics Businesswire
05-Jan-2022 Garuda Therapeutics Announces Appointment of Laurence Reid to Board of Directors Businesswire
05-Jan-2022 Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart Businesswire
05-Jan-2022 Global Laser Processing Market Forecasts Report 2021-2026 - ResearchAndMarkets.com Businesswire
05-Jan-2022 DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer Businesswire
05-Jan-2022 Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1 Businesswire
05-Jan-2022 NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities Businesswire
05-Jan-2022 Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO Businesswire
05-Jan-2022 Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board Businesswire
05-Jan-2022 Magenta Therapeutics to Present at the J.P. Morgan Healthcare Conference and the B. Riley Virtual Oncology Conference Businesswire
05-Jan-2022 Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants Businesswire
05-Jan-2022 Equillium to Present at the H.C. Wainwright Virtual BioConnect Conference Businesswire
05-Jan-2022 Exelixis Announces Enrollment Completion in Phase 3 CONTACT-03 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Previously Treated Metastatic Renal Cell Carcinoma Businesswire
05-Jan-2022 Peptilogics Receives Award from the Cystic Fibrosis Foundation to Investigate PLG0301 and PLG0206 as Potential Dual-Acting Treatments for Lung Infections Associated with Cystic Fibrosis Businesswire
05-Jan-2022 Inscripta® Appoints Kristala Prather, PhD to its Board of Directors Businesswire